Media Room
-
In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster
23 November 2022
Tom Hickey, Med Tech Gurus -
Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales
15 November 2022
Virax Biolabs, Press Releases -
Virax Biolabs Announces Closing of $3.8 Million Private Placement
8 November 2022
Virax Biolabs, Press Releases -
Virax Biolabs Announces $3.8 Million Private Placement
4 November 2022
Virax Biolabs, Press Releases -
Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit
3 November 2022
Virax Biolabs, Press Releases -
Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
26 October 2022
Virax Biolabs, Press Releases -
Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology
30 September 2022
Radio Interview, Health Professional Radio -
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.
22 September 2022
Virax Biolabs, Press Releases -
Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit
20 September 2022
Virax Biolabs, Press Releases -
Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference
12 September 2022
Virax Biolabs, Press Releases -
Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY
6 September 2022
Virax Biolabs, Press Releases -
Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering
16 August 2022
Virax Biolabs, Press Releases -
Benzinga Interview with Chief Executive, James Foster
4 August 2022
Video Interview, Benzinga -
Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
26 July 2022
Virax Biolabs, Press Releases -
Virax Biolabs Bucks the Market Trend
26 July 2022
Video Interview, Proactive -
Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX
21 July 2022
Virax Biolabs, Press Releases -
Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering
20 July 2022
Virax Biolabs, Press Releases -
Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders
31 May 2022
Virax Biolabs, Press Releases -
Virax Biolabs Introduces New Board of Directors, Announces Members
17 May 2022
Virax Biolabs, Press Releases -
Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research
9 May 2022
Virax Biolabs, GlobeNewswire -
Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer
28 April 2022
Virax Biolabs, Press Release -
Common cold may protect against SARS-CoV-2 infection and lead the way to new vaccines
14 January 2022
Katharine Lang, Medical News Today -
EXPLAINED: You May Never Forget The Omicron Variant, Here's Why Your T Cells Certainly Won't Anytime Soon
31 December 2021
Kenneth Mohanty, News 18 -
Beyond the spike: Are T cell COVID-19 vaccines the future?
20 December 2021
Debbie Lambert, Medical News Today -
Sales of PPE in the UK overtake sandwiches with the masks and hand sanitiser industry now worth more than £8.7BILLION
21 September 2020
Jack Elsom, Daily Mail -
Coronavirus warning: The 5 most likely places to catch coronavirus in an office
9 September 2020
Georgina Laud, Express -
Experts reveal ‘Covid hotspots’ in the office – and how to limit your risk
7 September 2020
Natalie Morris, Metro -
Face coverings to be made compulsory on public transport in England
4 June 2020
Rowena Mason, The Guardian